Clinical trial

POcus INTERvention for Tailoring Diuretic Strategy in Acute Decompensated Heart Failure

NCT07469722

StatusNOT_YET_RECRUITING

Study typeINTERVENTIONAL

Start date2026-03-23

PhasePHASE2 / PHASE3

Study timeline

Study start (estimated)2026-03-23Date precision: day

Registry last updated2026-03-18

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Acute Heart Failure (AHF)unresolved

Congestive Heart Failure Acuteunresolved

Diuretic Effectunresolved

Lung Ultrasonography Scoreunresolved

Ultrasonography, Dopplerunresolved

Point-of-care Ultrasound (POCUS)unresolved

Interventions

Furosemide 40 Milligrams.DRUG

Furosemide 40 Milligrams.DRUG

Hydrochlorothiazide (HCTZ) 25 milligrams.DRUG

Acetazolamide 250 milligrams.DRUG

Dapagliflozin (10mg Tab)DRUG

Potassium Chloride Oral ProductDRUG

Sponsors & collaborators

Hospital de Clinicas de Porto Alegrelead sponsor

Mapped research locations

Porto AlegreRio Grande do Sul, Brazil1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT07469722 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.